Press release
Hormonal Contraceptive Market Key Players| Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc.
The global hormonal contraceptive market was valued at $13,924 million in 2016, and is estimated to reach $16,018 million by 2023, registering a CAGR of 1.9% from 2017 to 2023. Hormonal contraception is a birth control method, which acts on the endocrine system, and is composed of steroid hormones. Higher concentration of naturally forming hormones such as estrogen and progesterone are used to either prevent ovulation or make unfavourable condition to develop pregnancy.
Request for Sample @ https://www.kdmarketinsights.com/sample/3885
Increase in adoption of hormonal contraceptives products or birth control methods in the developing countries and incidence of polycystic ovary syndrome (PCOS) are the major driving factors for the growth of the global hormonal contraceptive market. Moreover, rise in population attaining higher education and rise in need to control the ever-growing population in developing regions such as China and India have adopted measures to prevent unwanted pregnancy, which are expected to fuel the market growth. However, availability of alternate contraceptive methods and health risks associated with the use of contraceptives hamper the market growth.
The global hormonal contraceptive market is segmented on the basis of product, hormone, age group, end user, and geography. Based on product, the market is classified into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal rings, and transdermal patches. Depending on hormone, it is bifurcated into progestin-only contraceptive and combined hormonal contraceptive. By age group, it is categorized into 15-24 years, 25-34 years, 35-44 years, and above 44 years. By end user, it is classified into hospitals, household, and clinics. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
- This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
- The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
- In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
- The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product
- Oral Contraceptive Pills
- Injectable Birth Control
- Emergency Contraceptive Pills
- Vaginal Rings
- Transdermal Patches
By Hormone
- Progestin-only Contraceptive
- Combined Hormonal Contraceptive
By Age Group
- 15-24 Years
- 25-34 Years
- 35-44 Years
- Above 44 Years
By End User
- Hospitals
- Household
- Clinics
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY PLAYERS PROFILED
- The Female Health Company
- Teva Pharmaceutical Industries Limited
- Bayer AG
- Pfizer, Inc.
- Mylan N.V.
- Johnson & Johnson
- Ansell Ltd.
- Mayer Laboratories
- Merck & Co., Inc.
- Church & Dwight, Co., Inc.
The other players of the hormonal contraceptive market include (companies not profiled in the report):
- Reckitt Benckiser Plc.
- Warner Chilcott Company
- BioSante Pharmaceuticals Inc.
- HLL Lifecare Limited
- Boehringer Ingelheim GmbH
- Watson Pharmaceuticals, Inc.
- V-Care Pharma Pvt. Ltd.
- Vardhman Life Care Pvt. Ltd.
- Cipla Limited
Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/hormonal-contraceptive-market-amr
Table of Contents:
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. Top Player Positioning, 2016
3.4. Porters Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Rise in need for preventing unwanted pregnancy
3.5.1.2. Increasing awareness for contraceptives worldwide
3.5.1.3. Rising usage of oral contraceptives as a preferred method to avoid unplanned pregnancy
3.5.1.4. Technological advancements in contraceptive methods
3.5.1.5. Upsurge in government and NGO initiatives promoting contraceptives
3.5.2. Restrains
3.5.2.1. Health risks associated with the use of contraceptive methods
3.5.2.2. Lack of social acceptance
3.5.3. Opportunities
3.5.3.1. Rise in disposable income and demand for healthy life in emerging economies
3.5.3.2. Presence of large unmet contraceptive needs in emerging Asian and African economies
CHAPTER 4: HORMONAL CONTRACEPTIVE MARKET BY PRODUCT
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Oral Contraceptive Pills
4.2.1. Key market trends & growth opportunities
4.2.2. Market Size and Forecast
4.2.3. Market Analysis, by Country
4.3. Injectable Birth Control
4.3.1. Key market trends & growth opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.4. Emergency Contraceptive Pills
4.4.1. Key market trends & growth opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country
4.5. Vaginal Rings
4.5.1. Key market trends & growth opportunities
4.5.2. Market Size and Forecast
4.5.3. Market Analysis, by Country
4.6. Transdermal Patches
4.6.1. Key market trends & growth opportunities
4.6.2. Market Size and Forecast
4.6.3. Market Analysis, by Country
CHAPTER 5: HORMONAL CONTRACEPTIVE MARKET BY HORMONE
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Progestin-only Contraceptive
5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country
5.3. Combined Hormonal Contraceptive
5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country
CHAPTER 6: HORMONAL CONTRACEPTIVE MARKET BY AGE GROUP
6.1. Overview
6.1.1. Market Size and Forecast
6.2. 15-24 years
6.2.1. Market Size and Forecast
6.2.2. Market Analysis, by Country
6.3. 25-34 years
6.3.1. Market Size and Forecast
6.3.2. Market Analysis, by Country
6.4. 35-44 years
6.4.1. Market Size and Forecast
6.4.2. Market Analysis, by Country
6.5. Above 44 years
6.5.1. Market Size and Forecast
6.5.2. Market Analysis, by Country
CHAPTER 7: HORMONAL CONTRACEPTIVE MARKET BY END USERS
7.1. Overview
7.1.1. Market Size and Forecast
7.2. Hospitals
7.2.1. Market Size and Forecast
7.2.2. Market Analysis, by Country
7.3. Household
7.3.1. Market Size and Forecast
7.3.2. Market Analysis, by Country
7.4. Clinics
7.4.1. Market Size and Forecast
7.4.2. Market Analysis, by Country
Continue….
Check for Discount @ https://www.kdmarketinsights.com/discount/3885
Contact Us:
KD Market Insights
90 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: info@kdmarketinsights.com
Website: www.kdmarketinsights.com
Read More News:
https://foodandbeverages11.blogspot.com/
https://share7.home.blog/
About Us:
KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends. Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Research, you always have the choice of getting customized report free of cost (up to 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 500 companies and leading advisory firms.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hormonal Contraceptive Market Key Players| Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc. here
News-ID: 1867946 • Views: …
More Releases from KD Market Insights
Bucket Trucks Market Top Key Players - Manitowoc Cranes, Manitex International I …
The bucket trucks are utilitarian vehicles having a hydraulic pole or boom with a bucket at one end that can transport cargo or people. The hydraulic pole pulls the person up with the help of the bucket, allowing him to continue working while being safe. Additionally, these vehicles can be affixed to trailers or commercial vans.
They are extensively employed in many different industries, including the management of vegetation, lighting,…
Solar-Powered Car Market Top Key Players - Audi AG, Sono Motors GmbH, Lightyear, …
The solar-powered automobile is an electric car that draws its power from the sun. The photovoltaic cells are used to transform solar energy into electrical power to drive the vehicle. On such vehicles, solar panels with photovoltaic cells are attached. Electricity is generated by solar panels and stored in batteries.
The car's charged batteries power the motor, which acts as the vehicle's engine and propels the vehicle forward. The demand…
Trailer Terminal Tractor Market Top Key Players - AB Volvo, Mol CY nv, Orange EV …
The trailer terminal tractor is a specialized truck created for the quick, safe, and effective movement of semi-trailers or cargo containers. It is intended specifically for material loading and unloading. It operates quickly and efficiently, has a quick turnaround time, high level of dependability, good mobility, delivers exceptional comfort, and has servicing points that are conveniently located. To handle semi-trailers, roll trailers, container chassis, and heavy-duty trailers, it is mostly…
Robotics as a service Market Size is Reach at $6.8Bn by the end of 2025 – KD M …
The Global robotics as a service market was valued at USD 1.8 Billion as of the year 2019 and is expected to grow to about USD 6.8 Billion by 2025’s end and growing at an annual compound growth rate (CAGR) of 6 percent during the timeframe 2019-2025. Robotics as a Service (RaaS) is an aspect of artificial intelligence (AI) that integrates cloud computing with shared service. Companies are increasingly adopting this Robot as a…
More Releases for Contraceptive
Prominent Contraceptive Devices Market Trend for 2025: Innovative Products In Th …
What industry-specific factors are fueling the growth of the contraceptive devices market?
The rising prevalence of sexually transmitted diseases (STDs) is expected to fuel the growth of the contraceptive device market. STDs, influenced by increased sexual activity and insufficient protection, are on the rise, making contraceptive devices, especially condoms, essential for reducing transmission risks. The UK Health Security Agency reported a 4.7% increase in new STI diagnoses in England in 2023,…
Contraceptive Devices Market - Revolutionizing Family Planning: Cutting-Edge Con …
Newark, New Castle, USA: The "Contraceptive Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Contraceptive Devices Market: https://www.growthplusreports.com/report/contraceptive-devices-market/7763
This latest report researches the industry structure, sales, revenue,…
Contraceptive Drugs Market: Doctors on the cusp of launching the first male cont …
Contraceptive Drugs Market by Product (Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives), Age Group (15-24 Years, 25-34 Years, 35-44 Years, and Above 44 Years), and End User (Homecare, Hospitals, and Clinics): Global Opportunity Analysis and Industry Forecast, 2020-2027.
Download Sample Report at:
https://www.alliedmarketresearch.com/request-sample/9850
The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during…
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,…
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
